FSD Pharma Registered (B) Forum: Community User: Jo74

Tim Taler Das hatten wir schon in den 70er 😎

War kurz aber schön! Den Rest nehmen die Amis später mit.

werden die amis jetzt auch nochmal kaufen oder gewinne mitnehmen, so dass sich der Wert wieder bei

Die Covid-19 Fantasie lebt weiter

About FSD Pharma FSD Pharma Inc. is a publicly-traded holding company, since May 2018. FSD Pharma BioSciences, Inc., a wholly owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD201, by down-regulating the cytokines to effectuate an anti-inflammatory response. Forward-Looking Statements Neither the Canadian Securities Exchange nor its regulation services provider accept responsibility for the adequacy or accuracy of this press release. Certain statements contained in this press release constitute "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws (collectively, "Forward-Looking Information"). Forward-Looking Information includes, but is not limited to, information with respect to FSD Pharma's strategy, plans or future financial or operating performance, receipt of any FDA approvals, the costs associated with such planned trials, FSD Pharma's ability to obtain required funding and the terms and timing thereof, and the development of any applications of FSD-201, by down-regulating the cytokines to effectuate an anti-inflammatory response, receipt of applicable Health Canada approvals and the associated timing, and the terms and timing of any potential sale of the Company's Cobourg facility and adjacent real estate.

FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc. Thursday, July 30, 2020 2:30 AM FV Pharma to shut down operations within 30 days TORONTO, ON / ACCESSWIRE / July 30, 2020 / FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) ("FSD Pharma" or the "Company") today announced that it has notified Health Canada of the Company's decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. ("FV Pharma") and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma has begun the process of liquidating all FV Pharma assets, including the sale of the Company's cannabis production facility in Cobourg, Ontario. "It is now clear to us that our shareholder value is best served in closing down our medicinal grade cannabis operation in Cobourg, Ontario and reinforcing steps to advance pharmaceutical R&D efforts on our lead compound FSD201 (ultra-micronized PEA) and continuing to explore the acquisition of other compelling compounds to expand our drug development pipeline," said Raza Bokhari, MD, Executive Co-Chairman & CEO. "Our pharmaceutical R&D team led by Dr. Edward Brennan is actively working to submit an Investigational New Drug Application (IND) to the FDA for the use of FSD201 (ultra-micronized PEA) to treat hospitalized COVID-19 patients by down-regulating the over-expressed pro-inflammatory cytokine immune response to SARS-CoV-2 virus infection. We are hopeful to initiate the phase 2 clinical trial before the end of this year and remain cautiously optimistic that our study may improve treatment outcome for COVID-19 patients." The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

Es ging hoch weil sie ihre cannabis Lizenz abgegeben haben! Der Grund ist, das einige in solche Unternehmen nicht investieren würden.

Immer noch stabil bei etwa 7 €

da ist er wieder ... der Peak

Warte bis die Amis kommen

Unter runter geht's 🙈

Damit die 🦈was zum fressen bekommen..

Geht ab 😎

Die hat hier auch noch viel aufzuholen. Soll man gad geben hier

Die Geier stürzen sich doch auf alles im Augenblick